Showing results (331-340 of 351) with videos related to

Sort By:
Pageof 36
Bioorganic & Medicinal Chemistry Letters|December 17, 2013
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Health Technology Assessment (Winchester, England)|July 29, 2022
Offer of a bandage versus rigid immobilisation in 4- to 15-year-olds with distal radius torus fractures: the FORCE equivalence RCTDaniel C Perry, Juul Achten, Ruth Knight, et al.
Orthopaedic Journal of Sports Medicine|February 17, 2023
The Use of Biologics in NFL Athletes: An Expert Consensus of NFL Team PhysiciansIain R Murray, Timothy R McAdams, Kyle E Hammond, et al.
Vaccine|April 20, 2011
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccineDavid W Porter, Fiona M Thompson, Tamara K Berthoud, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitorsStephen M Courtney, Philip A Hay, Richard T Buck, et al.
Plos One|January 31, 2008
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trialFiona M Thompson, David W Porter, Shinji L Okitsu, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Pageof 36